Cortalix
Groningen · Founded 2007
About Cortalix
Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics, and diagnostics for novel targets based on its proprietary platform of synthetic single domain antibodies in close partnerships with companies.
Company Facts
- Founded: 2007
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: https://cortalix.com/
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cortalix-40696 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.